Saturday, July 5, 2025 7/5/2025

Investigating the effects of aerobic and resistance training in vivo on skeletal muscle metabolism in vitro in primary human muscle cells (MoTrMyo)

Award Number: R01DK120322
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2019
PERIOD OF PERFORMANCE END DATE: 05/31/2026

Group Awards By:

View Award Description

Investigating the effects of aerobic and resistance training in vivo on skeletal muscle metabolism in vitro in primary human muscle cells (MoTrMyo) - Project Summary/Abstract Low exercise capacity is an important risk factor for all-cause morbidity and mortality. Skeletal muscle is a critical component of exercise capacity through its ability to generate ATP via mitochondrial substrate oxidation (i.e. mitochondrial function). Skeletal muscle properties also influence whole-body insulin sensitivity which affects risk for metabolic diseases (e.g. type 2 diabetes, obesity). Nascent myogenic progenitor cells are a critical component of skeletal muscle plasticity in response to exercise as they proliferate, self‐renew and pass on epigenetic modifications to daughter populations. Meager evidence suggests that these progenitor cells are “imprinted” by lifestyle interventions which confers subsequent metabolic adaptations. The proposed studies will fill a gap in our knowledge and directly assess the ability of exercise training to imprint myogenic progenitor cells in a manner leading to improved exercise capacity and reduced risk for metabolic disease. The primary goal of the present proposal is to leverage the MoTrPAC parent project and determine the distinct abilities of short-term (three months) and life-long (athletes) aerobic training (AT) and resistance training (RT) to imprint key myocellular metabolic properties (insulin sensitivity, mitochondrial function) through epigenetic regulation (DNA methylation, RNA expression) of novel exercise response genes in skeletal muscle progenitor cells. Our secondary goal is to establish a human primary skeletal muscle cell (HSkMC) culture repository from MoTrPAC which can be utilized for future mechanistic interrogations. We hypothesize that exercise training will imprint metabolic properties in skeletal muscle progenitor cells through epigenetic regulation of novel exercise response genes that will differ between AT and RT. We will establish HSkMC cultures from muscle biopsies of 325 individuals (AT, RT, control groups) before and following three months of intervention and 75 athletes (AT and RT) and assess insulin action (insulin-stimulated glycogen synthesis, insulin signal transduction), mitochondrial function (O2 consumption using carbohydrate and fatty acid substrates), DNA methylation and RNA expressions (RNAseq) with associated pathway enrichment analyses. The stated purpose of Aim 1 is to determine the distinct abilities of short-term and life-long AT and RT to imprint key myocellular metabolic properties (insulin sensitivity, mitochondrial function) through epigenetic regulation of exercise response genes. Integration of DNA methylation and RNAseq data will identify novel exercise response genes for subsequent genetic manipulation in vitro to determine its effects on the stated metabolic endpoints. The stated purpose of Aim 2 is to create an HSkMC repository for future investigations. Findings from the proposed studies will provide unprecedented mechanistic insight into the ability of exercise training to confer a “metabolic memory” through epigenetic modification of specific exercise response genes and inform subsequent exercise prescriptions relative to optimizing health benefits gained from exercise.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	ADVENTIST HEALTH SYSTEM/SUNBELT INC	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5	6/9/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $596,250 )
2024	2024	ADVENTIST HEALTH SYSTEM/SUNBELT INC	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5	5/13/2024	NON-COMPETING CONTINUATION	$596,250
														Subtotal = $596,250

Issue Date FY: 2023 ( Subtotal = $667,615 )
2023	2023	ADVENTIST HEALTH SYSTEM/SUNBELT, INC.	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	5/10/2023	NON-COMPETING CONTINUATION	$667,615
														Subtotal = $667,615

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2021	ADVENTIST HEALTH SYSTEM/SUNBELT, INC.	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	7/14/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $674,785 )
2021	2021	ADVENTIST HEALTH SYSTEM/SUNBELT, INC.	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	8/6/2021	NON-COMPETING CONTINUATION	$674,785
														Subtotal = $674,785

Issue Date FY: 2020 ( Subtotal = $700,480 )
2020	2020	ADVENTIST HEALTH SYSTEM/SUNBELT, INC.	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	002	2	7/31/2020	NON-COMPETING CONTINUATION	$700,480
2020	2019	ADVENTIST HEALTH SYSTEM/SUNBELT, INC.	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	1	5/4/2020	NEW	$0
2020	2019	ADVENTIST HEALTH SYSTEM/SUNBELT, INC.	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	11/5/2019	NEW	$0
														Subtotal = $700,480

Issue Date FY: 2019 ( Subtotal = $768,609 )
2019	2019	ADVENTIST HEALTH SYSTEM/SUNBELT, INC.	601 E ROLLINS ST	ORLANDO	FL	32803	ORANGE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	7/26/2019	NEW	$768,609
														Subtotal = $768,609

Grand Total All Awards = $3,407,739

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating the effects of aerobic and resistance training in vivo on skeletal muscle metabolism in vitro in primary human muscle cells (MoTrMyo)

Award Number: R01DK120322

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2019

PERIOD OF PERFORMANCE END DATE: 05/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer